These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1355384)

  • 21. A carbocyclic nucleoside analogue is a TNF-alpha inhibitor with immunosuppressive action: role of prostaglandin E2 and protein kinase C and comparison with pentoxifylline.
    Al-Humidan A; Edwards CK; Al-Sofi A; Dzimiri M; Al-Sedairy ST; Khabar KS
    Cell Immunol; 1998 Aug; 188(1):12-8. PubMed ID: 9743553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic bone marrow inhibits T-cell activation and clonal expansion in vitro.
    George JF; Lu A; Thomas JM; Kirklin JK; Pinderski LJ
    Transplantation; 2003 Jul; 76(1):237-43. PubMed ID: 12865816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive activity of cyclosporine metabolites in vitro.
    Schlitt HJ; Christians U; Wonigeit K; Sewing KF; Pichlmayr R
    Transplant Proc; 1987 Oct; 19(5):4248-51. PubMed ID: 2960052
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative effects of tumor necrosis factor-alpha and IL-1 beta on mitogen-induced T cell activation.
    Hackett RJ; Davis LS; Lipsky PE
    J Immunol; 1988 Apr; 140(8):2639-44. PubMed ID: 2965728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
    Huet S; Boumsell L; Dausset J; Degos L; Bernard A
    Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation.
    Bianco JA; Appelbaum FR; Nemunaitis J; Almgren J; Andrews F; Kettner P; Shields A; Singer JW
    Blood; 1991 Sep; 78(5):1205-11. PubMed ID: 1878587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD44 contributes to T cell activation.
    Huet S; Groux H; Caillou B; Valentin H; Prieur AM; Bernard A
    J Immunol; 1989 Aug; 143(3):798-801. PubMed ID: 2568380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytochalasins enhance the proliferation of CD4 cells through the CD3-Ti antigen receptor complex or the CD2 molecule through an effect on early events of activation.
    Matsuyama T; Yamada A; Deusch K; Sleasman J; Daley JF; Torimoto Y; Abe T
    J Immunol; 1991 Jun; 146(11):3736-41. PubMed ID: 1709660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoregulatory functions of paf-acether. II. Decrease of CD2 and CD3 antigen expression.
    Vivier E; Salem P; Dulioust A; Praseuth D; Metezeau P; Benveniste J; Thomas Y
    Eur J Immunol; 1988 Mar; 18(3):425-30. PubMed ID: 2895712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation.
    Dang NH; Torimoto Y; Sugita K; Daley JF; Schow P; Prado C; Schlossman SF; Morimoto C
    J Immunol; 1990 Dec; 145(12):3963-71. PubMed ID: 1979581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.
    Hill GR; Teshima T; Gerbitz A; Pan L; Cooke KR; Brinson YS; Crawford JM; Ferrara JL
    J Clin Invest; 1999 Aug; 104(4):459-67. PubMed ID: 10449438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunodeficiency with low expression of the T cell receptor/CD3 complex. Effect on T lymphocyte activation.
    Le Deist F; Thoenes G; Corado J; Lisowska-Grospierre B; Fischer A
    Eur J Immunol; 1991 Jul; 21(7):1641-7. PubMed ID: 1676369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA typing using IL-2 activated T lymphocytes: usefulness in pediatric candidates for allogeneic bone marrow transplantation.
    Kubo K; Tachino J; Ichikawa S; Hamamoto K; Ueda K
    Bone Marrow Transplant; 1991 Sep; 8(3):185-90. PubMed ID: 1720338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T lymphocyte depletion of human peripheral blood and bone marrow using monoclonal antibodies and magnetic microspheres.
    Gee AP; Lee C; Sleasman JW; Madden M; Ugelstad J; Barrett DJ
    Bone Marrow Transplant; 1987 Aug; 2(2):155-63. PubMed ID: 2901878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
    Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
    Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence that protein kinase C differentially regulates the human T lymphocyte CD2 and CD3 surface antigens.
    Cantrell DA; Verbi W; Davies A; Parker P; Crumpton MJ
    Eur J Immunol; 1988 Sep; 18(9):1391-6. PubMed ID: 2901966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct regulatory effects of IL-4 and TNF-alpha during CD3-dependent and CD3-independent initiation of human T-cell activation.
    Damle NK; Doyle LV
    Lymphokine Res; 1989; 8(2):85-97. PubMed ID: 2525210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha.
    Yokota S; Geppert TD; Lipsky PE
    J Immunol; 1988 Jan; 140(2):531-6. PubMed ID: 3257243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic effect of the rapamycin-cyclosporine combination: median effect analysis of in vitro immune performances by human T lymphocytes in PHA, CD3, and MLR proliferative and cytotoxicity assays.
    Kahan BD; Gibbons S; Tejpal N; Chou TC; Stepkowski S
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1090-1. PubMed ID: 1824888
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.
    Harrop JA; Reddy M; Dede K; Brigham-Burke M; Lyn S; Tan KB; Silverman C; Eichman C; DiPrinzio R; Spampanato J; Porter T; Holmes S; Young PR; Truneh A
    J Immunol; 1998 Aug; 161(4):1786-94. PubMed ID: 9712045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.